|
BIO
After wrapping up in Boston a couple weeks ago, future BIO conference locations have been announced. Thankfully, it will not be returning to San Francisco any time soon (no offense, but c’mon). Here’s the announced schedule for the next four years:
2024: San Diego
2025: Boston
2026: San Diego
2027: Philadelphia
San Diego every other year? Forever, please.
Only source for this schedule seems to be Twitter posts, but when has Twitter ever been wrong about anything?
Colon Cancel
Look at these clowns, making our lives difficult and naming themselves Generate:Biomedicines.
Since company names have no right to subtitles, they will be known as Generate Biomedicines in the BioPharmGuy directory.
No colon for you!
Outcome Mercky
The Inflation Reduction Act, which did nothing to address inflation, but did allow federal agencies more leeway in negotiating drug prices with companies who wish to sell to Medicare, is the target of a constitutional lawsuit courtesy of American Merck. They allege their 5th amendment rights are being violated.
Pardon us while our laughter subsides.
Besides the more familiar aspect of the 5th amendment, namely the right to not self-incriminate, there is a little mention at the end allowing “…nor shall private property be taken for public use, without just compensation.”
This clause is applicable to eminent domain, but as far as we know, the inflation reduction act isn’t forcing drug companies to sell their products to the federal government. They’re welcome to keep them in the warehouses if they want.
This lawsuit seems way off base and likely yet another exercise in the futility of improving the pharmaceutical industry’s image.
The company makes a point that the IRA seems to force companies to sell everything to the government cheaply or sell nothing to the government. And that may be true and also unfair. But it will be a rough ride through the federal courts for Merck & Co.
Hopewell Therapeutics
Nothing wrong with this new company's name, but they do have a hyphen in their domain name, which is ok if the one they really wanted was taken. But their emails are for hopewelltx.com without the hyphen. Which means they own the hyphen-less domain.
If you own the hyphen-less domain, use it!
(It's a veritable tyranny of punctuation problems this week.)
Bless Their Hearts
A company appearing in the defunct section of BioPharmGuy is suing Moderna and BioNTech for violating its patents.
Always worth a shot for a dying company to try to strike it rich. Who knows, maybe they’ll get a settlement. They do seem to have some mRNA-related patents, but good luck finding a judge and jury who can understand any of it.
Gene Bio Medical
In a case where a lazy company threw three life science terms together and called it a day, we added ‘Gene Bio Medical’ to our directory this week.
Not only is it uninspired, but that's one space too many. Either GeneBio Medical or Gene Biomedical would have flowed better. (But still would have stunk.)
2/10
T-eam Roast - Alopexx
The CFO of Alopexx is named Thomas T. Thomas. Do they include the middle initial to tease (sorry) us about the possible middle name or simply to make sure we realize they didn’t mistakenly write a first name twice?
Google didn’t unearth the meaning behind that middle T, but did show us he owns a 36-acre winery in California cleverly named the Thomas T. Thomas Vineyard. (Try the pinot.)
T-eam Roast - Tscan
Continuing with the T theme, the profile for TScan's CEO says he "relaxes by running marathons and ultramarathons".
Well. Look. At. You.
They could have just as easily said “relaxes by being better than you” and gotten the point across while sparing us the exhausting details.
| 
